third-generation packaging system Search Results


third-generation packaging plasmids  (Shanghai GenePharma)
90
Shanghai GenePharma third-generation packaging plasmids
Third Generation Packaging Plasmids, supplied by Shanghai GenePharma, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/third-generation packaging plasmids/product/Shanghai GenePharma
Average 90 stars, based on 1 article reviews
third-generation packaging plasmids - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
third-generation lentiviral packaging system  (Cell Genesys)
90
Cell Genesys third-generation lentiviral packaging system
Third Generation Lentiviral Packaging System, supplied by Cell Genesys, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/third-generation lentiviral packaging system/product/Cell Genesys
Average 90 stars, based on 1 article reviews
third-generation lentiviral packaging system - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
third generation lentiviral packaging plasmids  (SIRION Biotech)
90
SIRION Biotech third generation lentiviral packaging plasmids
Third Generation Lentiviral Packaging Plasmids, supplied by SIRION Biotech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/third generation lentiviral packaging plasmids/product/SIRION Biotech
Average 90 stars, based on 1 article reviews
third generation lentiviral packaging plasmids - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
third-generation packaging system  (Biowit Technologies)
90
Biowit Technologies third-generation packaging system
Third Generation Packaging System, supplied by Biowit Technologies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/third-generation packaging system/product/Biowit Technologies
Average 90 stars, based on 1 article reviews
third-generation packaging system - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
third-generation lentivirus packaging system (vector: packaging plasmid: envelope ratio = 10:3:1  (Promega)
90
Promega third-generation lentivirus packaging system (vector: packaging plasmid: envelope ratio = 10:3:1
Third Generation Lentivirus Packaging System (Vector: Packaging Plasmid: Envelope Ratio = 10:3:1, supplied by Promega, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/third-generation lentivirus packaging system (vector: packaging plasmid: envelope ratio = 10:3:1/product/Promega
Average 90 stars, based on 1 article reviews
third-generation lentivirus packaging system (vector: packaging plasmid: envelope ratio = 10:3:1 - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
third-generation lentiviral packaging system  (Promega)
90
Promega third-generation lentiviral packaging system
Third Generation Lentiviral Packaging System, supplied by Promega, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/third-generation lentiviral packaging system/product/Promega
Average 90 stars, based on 1 article reviews
third-generation lentiviral packaging system - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
modified third-generation packaging system  (Biowit Technologies)
90
Biowit Technologies modified third-generation packaging system
Modified Third Generation Packaging System, supplied by Biowit Technologies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/modified third-generation packaging system/product/Biowit Technologies
Average 90 stars, based on 1 article reviews
modified third-generation packaging system - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
generation lentiviral system targeting plau  (Shanghai Genechem Ltd)
86
Shanghai Genechem Ltd generation lentiviral system targeting plau
Figure 1. <t>PLAU</t> is overexpressed in cervical cancer. (A) PLAU expression in normal tissues and cervical cancer tissues based on the UALCAN data base. (B) Expression of PLAU in 16 cervical cancer tissues and matched tumor‑adjacent normal tissues was detected using reverse transcription‑quan titative PCR. *P<0.05. PLAU, plasminogen activator urokinase; TCGA, The Cancer Genome Atlas.
Generation Lentiviral System Targeting Plau, supplied by Shanghai Genechem Ltd, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/generation lentiviral system targeting plau/product/Shanghai Genechem Ltd
Average 86 stars, based on 1 article reviews
generation lentiviral system targeting plau - by Bioz Stars, 2026-05
86/100 stars
  Buy from Supplier
thirdgeneration packaging systems  (Shanghai Genechem Ltd)
86
Shanghai Genechem Ltd thirdgeneration packaging systems
Figure 1. <t>PLAU</t> is overexpressed in cervical cancer. (A) PLAU expression in normal tissues and cervical cancer tissues based on the UALCAN data base. (B) Expression of PLAU in 16 cervical cancer tissues and matched tumor‑adjacent normal tissues was detected using reverse transcription‑quan titative PCR. *P<0.05. PLAU, plasminogen activator urokinase; TCGA, The Cancer Genome Atlas.
Thirdgeneration Packaging Systems, supplied by Shanghai Genechem Ltd, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/thirdgeneration packaging systems/product/Shanghai Genechem Ltd
Average 86 stars, based on 1 article reviews
thirdgeneration packaging systems - by Bioz Stars, 2026-05
86/100 stars
  Buy from Supplier

Image Search Results


Figure 1. PLAU is overexpressed in cervical cancer. (A) PLAU expression in normal tissues and cervical cancer tissues based on the UALCAN data base. (B) Expression of PLAU in 16 cervical cancer tissues and matched tumor‑adjacent normal tissues was detected using reverse transcription‑quan titative PCR. *P<0.05. PLAU, plasminogen activator urokinase; TCGA, The Cancer Genome Atlas.

Journal: Oncology reports

Article Title: PLAU is associated with cell migration and invasion and is regulated by transcription factor YY1 in cervical cancer.

doi: 10.3892/or.2022.8462

Figure Lengend Snippet: Figure 1. PLAU is overexpressed in cervical cancer. (A) PLAU expression in normal tissues and cervical cancer tissues based on the UALCAN data base. (B) Expression of PLAU in 16 cervical cancer tissues and matched tumor‑adjacent normal tissues was detected using reverse transcription‑quan titative PCR. *P<0.05. PLAU, plasminogen activator urokinase; TCGA, The Cancer Genome Atlas.

Article Snippet: The lentiviral vectors (Lv)‐small hairpin RNA (shRNA) based on a 3rd generation lentiviral system targeting PLAU (Lv‐shSPP1), Lv‐shYY1, and negative control (Lv‐shCon) were purchased from Shanghai GeneChem Co., Ltd.

Techniques: Expressing

Figure 2. Knockdown of PLAU inhibits cell proliferation, migration and invasion of cervical cancer. (A) PLAU mRNA expression in HeLa and HT3 cells infected with Lv‑shCon or Lv‑shPLAU. (B and C) The proliferation of (B) HeLa and (C) HT3 cells with Lv‑shCon or Lv‑shPLAU infection. (D) The migration and invasion of HeLa cells with Lv‑shCon or Lv‑shPLAU infection. (E) Counting of migratory and invasive HeLa cells. (F) Cell migration and invasion of HT3 cells with Lv‑shCon or Lv‑shPLAU infection. (G) Counting of migratory and invasive HT3 cells. (H and I) Expression of cyclin D1, MMP‑9, and E‑cadherin in (H) HeLa and (I) HT3 cells with Lv‑shCon or Lv‑shPLAU infection. *P<0.05. PLAU, plasminogen activator urokinase; Lv, lentiviral; sh‑, short hairpin.

Journal: Oncology reports

Article Title: PLAU is associated with cell migration and invasion and is regulated by transcription factor YY1 in cervical cancer.

doi: 10.3892/or.2022.8462

Figure Lengend Snippet: Figure 2. Knockdown of PLAU inhibits cell proliferation, migration and invasion of cervical cancer. (A) PLAU mRNA expression in HeLa and HT3 cells infected with Lv‑shCon or Lv‑shPLAU. (B and C) The proliferation of (B) HeLa and (C) HT3 cells with Lv‑shCon or Lv‑shPLAU infection. (D) The migration and invasion of HeLa cells with Lv‑shCon or Lv‑shPLAU infection. (E) Counting of migratory and invasive HeLa cells. (F) Cell migration and invasion of HT3 cells with Lv‑shCon or Lv‑shPLAU infection. (G) Counting of migratory and invasive HT3 cells. (H and I) Expression of cyclin D1, MMP‑9, and E‑cadherin in (H) HeLa and (I) HT3 cells with Lv‑shCon or Lv‑shPLAU infection. *P<0.05. PLAU, plasminogen activator urokinase; Lv, lentiviral; sh‑, short hairpin.

Article Snippet: The lentiviral vectors (Lv)‐small hairpin RNA (shRNA) based on a 3rd generation lentiviral system targeting PLAU (Lv‐shSPP1), Lv‐shYY1, and negative control (Lv‐shCon) were purchased from Shanghai GeneChem Co., Ltd.

Techniques: Knockdown, Migration, Expressing, Infection

Figure 3. Identification of the PLAU core promoter. (A) Based on the pGL3‑PLAU, a series of deletion mutants of the PLAU promoter (‑1500/+18, ‑1300/+18, ‑1100/+18, ‑900/+18, ‑700/+18, ‑500/+18, ‑300/+18) were constructed and transfected into HeLa cells to measure the luciferase activity. Left panel, the ideograph of the deletion mutants of the PLAU promoter; right panel, relative luciferase activity of each mutant. (B) Left panel, ideograph of the PLAU core promoter; right panel, relative luciferase activity. *P<0.05 vs. the ‑1500/+18. PLAU, plasminogen activator urokinase; luc, luciferase.

Journal: Oncology reports

Article Title: PLAU is associated with cell migration and invasion and is regulated by transcription factor YY1 in cervical cancer.

doi: 10.3892/or.2022.8462

Figure Lengend Snippet: Figure 3. Identification of the PLAU core promoter. (A) Based on the pGL3‑PLAU, a series of deletion mutants of the PLAU promoter (‑1500/+18, ‑1300/+18, ‑1100/+18, ‑900/+18, ‑700/+18, ‑500/+18, ‑300/+18) were constructed and transfected into HeLa cells to measure the luciferase activity. Left panel, the ideograph of the deletion mutants of the PLAU promoter; right panel, relative luciferase activity of each mutant. (B) Left panel, ideograph of the PLAU core promoter; right panel, relative luciferase activity. *P<0.05 vs. the ‑1500/+18. PLAU, plasminogen activator urokinase; luc, luciferase.

Article Snippet: The lentiviral vectors (Lv)‐small hairpin RNA (shRNA) based on a 3rd generation lentiviral system targeting PLAU (Lv‐shSPP1), Lv‐shYY1, and negative control (Lv‐shCon) were purchased from Shanghai GeneChem Co., Ltd.

Techniques: Construct, Transfection, Luciferase, Activity Assay, Mutagenesis

Figure 4. YY1 regulates PLAU expression at the transcriptional level. (A) A total of 8 transcriptional factors were predicted to bind to the PLAU core promoter according to PROMO software. (B) YY1 expression in normal and cervical cancer tissues based on the UALCAN database. (C) Expression of YY1 in 16 cervical cancer tissues and matched tumor‑adjacent normal tissues was detected using reverse transcription‑quantitative PCR. (D) Correlation of PLAU to YY1 expression in cervical cancers. (E) The migration and invasion of HeLa cells with Lv‑shCon or Lv‑shYY1 infection. (F) Counting of migratory and invasive HeLa cells. (G) mRNA expression levels of cyclin D1, MMP‑9, and E‑cadherin in HeLa cells with Lv‑shCon or Lv‑shYY1 infection. (H) The migration and invasion of HT3 cells with Lv‑shCon or Lv‑shYY1 infection. (I) Counting of migratory and invasive HT3 cells. (J) mRNA expression levels of cyclin D1, MMP‑9 and E‑cadherin in HT3 cells with Lv‑shCon or Lv‑shYY1 infection. (K) PLAU mRNA expression in HeLa cells with Lv‑shCon or Lv‑shYY1 infection. (L) PLAU core promoter activity in HeLa cells with Lv‑shCon or Lv‑shYY1 infection. *P<0.05. YY1, transcription factor YinYang 1; PLAU, plasminogen activator urokinase; Lv, lentiviral; sh‑, short hairpin.

Journal: Oncology reports

Article Title: PLAU is associated with cell migration and invasion and is regulated by transcription factor YY1 in cervical cancer.

doi: 10.3892/or.2022.8462

Figure Lengend Snippet: Figure 4. YY1 regulates PLAU expression at the transcriptional level. (A) A total of 8 transcriptional factors were predicted to bind to the PLAU core promoter according to PROMO software. (B) YY1 expression in normal and cervical cancer tissues based on the UALCAN database. (C) Expression of YY1 in 16 cervical cancer tissues and matched tumor‑adjacent normal tissues was detected using reverse transcription‑quantitative PCR. (D) Correlation of PLAU to YY1 expression in cervical cancers. (E) The migration and invasion of HeLa cells with Lv‑shCon or Lv‑shYY1 infection. (F) Counting of migratory and invasive HeLa cells. (G) mRNA expression levels of cyclin D1, MMP‑9, and E‑cadherin in HeLa cells with Lv‑shCon or Lv‑shYY1 infection. (H) The migration and invasion of HT3 cells with Lv‑shCon or Lv‑shYY1 infection. (I) Counting of migratory and invasive HT3 cells. (J) mRNA expression levels of cyclin D1, MMP‑9 and E‑cadherin in HT3 cells with Lv‑shCon or Lv‑shYY1 infection. (K) PLAU mRNA expression in HeLa cells with Lv‑shCon or Lv‑shYY1 infection. (L) PLAU core promoter activity in HeLa cells with Lv‑shCon or Lv‑shYY1 infection. *P<0.05. YY1, transcription factor YinYang 1; PLAU, plasminogen activator urokinase; Lv, lentiviral; sh‑, short hairpin.

Article Snippet: The lentiviral vectors (Lv)‐small hairpin RNA (shRNA) based on a 3rd generation lentiviral system targeting PLAU (Lv‐shSPP1), Lv‐shYY1, and negative control (Lv‐shCon) were purchased from Shanghai GeneChem Co., Ltd.

Techniques: Expressing, Software, Migration, Infection, Activity Assay

Figure 5. Identification of the binding site of YY1 on the PLAU promoter. (A) Site A and Site B were mutated separately or double‑mutated. (B) Luciferase activity of the PLAU promoter with separate Site A and Site B mutation, and with double mutation of Site A and Site B were measured in HeLa cells with Lv‑shCon or Lv‑shYY1 infection. *P<0.05. YY1, transcrip tion factor YinYang 1; PLAU, plasminogen activator urokinase; Lv, lentiviral; sh‑, short hairpin.

Journal: Oncology reports

Article Title: PLAU is associated with cell migration and invasion and is regulated by transcription factor YY1 in cervical cancer.

doi: 10.3892/or.2022.8462

Figure Lengend Snippet: Figure 5. Identification of the binding site of YY1 on the PLAU promoter. (A) Site A and Site B were mutated separately or double‑mutated. (B) Luciferase activity of the PLAU promoter with separate Site A and Site B mutation, and with double mutation of Site A and Site B were measured in HeLa cells with Lv‑shCon or Lv‑shYY1 infection. *P<0.05. YY1, transcrip tion factor YinYang 1; PLAU, plasminogen activator urokinase; Lv, lentiviral; sh‑, short hairpin.

Article Snippet: The lentiviral vectors (Lv)‐small hairpin RNA (shRNA) based on a 3rd generation lentiviral system targeting PLAU (Lv‐shSPP1), Lv‐shYY1, and negative control (Lv‐shCon) were purchased from Shanghai GeneChem Co., Ltd.

Techniques: Binding Assay, Luciferase, Activity Assay, Mutagenesis, Infection